Key result
Reduced right ventricular longitudinal function (TAPSE <17 mm) was positively associated with right ventriculoarterial coupling impairment (OR 1.41; 95% CI 1.07-1.87; P=0.015).
Why the study?
Right ventriculoarterial coupling has been little investigated in nonischemic dilated cardiomyopathy.
Does RHC/TTE-derived right ventriculoarterial coupling correlate with pulmonary hypertension types and RV functional status in patients with advanced heart failure and nonischemic dilated cardiomyopathy?
Cohort (n=68)
Does RHC/TTE-derived right ventriculoarterial coupling correlate with pulmonary hypertension types and RV functional status in patients with advanced heart failure and nonischemic dilated cardiomyopathy?
Odds Ratio: 1.41 (95% CI 1.07–1.87)
p-value: p=0.015
RHC/TTE-derived right ventriculoarterial coupling (R-V/A) provides comprehensive information on cardiopulmonary efficiency and correlates well with pulmonary hypertension types and RV functional status in NIDCM patients.
BACKGROUND: The right ventriculoarterial coupling (R-V/A), a measure of right ventricular systolic dysfunction (RVSD) adaptation/maladaptation to chronic overload, and consequent pulmonary hypertension, has been little investigated in nonischemic dilated cardiomyopathy (NIDCM). We examined the correlates of R-V/A and traditional echocardiographic indices of RVSD, over the spectrum of pulmonary hypertension and tertiles of mean pulmonary artery pressures (PAPm). METHODS: In 2016-2017, we studied 81 consecutive patients for heart transplant/advanced heart failure. Inclusion criteria were NIDCM, reduced ejection fraction (≤40%) and sinus rhythm. R-V/A was computed as the RV/pulmonary elastances ratio (R-Elv/P-Ea), derived from a combined right heart catheterization/transthoracic- echocardiographic assessment [right heart catheterization/transthoracic-echocardiographic (RHC/TTE)]. RESULTS: A total of 68 patients (mean age 64 ± 7 years, 82% men) were eligible. After adjustments, R-Elv and P-Ea were higher in isolated postcapillary-pulmonary hypertension (Ipc-PH) than combined-pulmonary hypertension (Cpc-PH) (P = 0.004 and P = 0.002, respectively), whereas R-V/A progressively decreased over Ipc-PH and Cpc-PH (P = 0.006). According to PAPm increment, P-Ea congruently increased (P-Trend = 0.028), R-Elv progressively decreased (P-Trend<0.00)1, whereas R-V/A significantly worsened (P-Trend = 0.045). At the multivariable analysis, a reduced RV longitudinal function (TAPSE<17 mm) was positively associated with R-V/A impairment (<0.8) [odds ratio 1.41, 95% confidence interval (CI) (1.07--1.87), P = 0.015]. R-Elv and P-Ea showed good interobserver reliability [interclass correlation (ICC) 0.84, 95% CI (0.32--0.99), P = 0.012 and ICC 0.98, 95% CI (0.93--99), P < 0.001, respectively]. CONCLUSION: Among NIDCM HF patients, in a small cohort study, RHC/TTE-derived R-V/A assessment demonstrated good correlations with pulmonary hypertension types and RV functional status. These data suggest that R-V/A encloses comprehensive information of the whole cardiopulmonary efficiency, better clarifying the amount of RVSD, with good reliability.
No takes yet. Share an insight, caveat, or question.
Bianco et al. (2020) conducted a cohort in Advanced heart failure with nonischemic dilated cardiomyopathy (n=68). Reduced RV longitudinal function (TAPSE <17 mm) was evaluated on Right ventriculoarterial coupling (R-V/A) impairment (<0.8) (OR 1.41, 95% CI 1.07-1.87, p=0.015). Reduced right ventricular longitudinal function (TAPSE <17 mm) was positively associated with right ventriculoarterial coupling impairment (OR 1.41; 95% CI 1.07-1.87; P=0.015).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: